Science to practice: Which approaches to combination interventional oncologic therapy hold the greatest promise of obtaining maximal clinical benefit?

Radiology

Volumn 261, Issue 3, 2011, Pages 667-669

  Goldberg, S Nahum ^a,b  

^a HADASSAH HEBREW UNIVERSITY MEDICAL CENTER   (Israel)

^b HARVARD MEDICAL SCHOOL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALCOHOL; BORTEZOMIB; DOXORUBICIN; FLUORODEOXYGLUCOSE F 18; LIPOSOME; PACLITAXEL; QUERCETIN; RHENIUM 186; SMALL INTERFERING RNA; YTTRIUM 90;

APOPTOSIS; ARTICLE; CANCER CHEMOTHERAPY; CANCER RADIOTHERAPY; CANCER SURVIVAL; CHEMOEMBOLIZATION; DRUG RETENTION; DRUG UPTAKE; HIGH INTENSITY FOCUSED ULTRASOUND; HUMAN; LIVER TUMOR; MULTIMODALITY CANCER THERAPY; NONHUMAN; PRIORITY JOURNAL; RADIOFREQUENCY ABLATION; TUMOR ABLATION; TUMOR REGRESSION; UNSPECIFIED SIDE EFFECT;

ANIMALS; ANTIBIOTICS, ANTINEOPLASTIC; CARCINOMA, SQUAMOUS CELL; DOXORUBICIN; HEAD AND NECK NEOPLASMS; RADIOPHARMACEUTICALS; RHENIUM;

EID: 81555200417     PISSN: 00338419     EISSN: 15271315     Source Type: Journal    
DOI: 10.1148/radiol.111906     Document Type: Article

References (21)

1. 186Re-labeled liposomal doxorubicin in combination with radiofrequency ablation for effective treatment of head and neck cancer in a nude rat tumor xenograft model. Radiology 2011;261(3):813-823.
2. Goldberg SN. Can tumor growth be further inhibited by combining drugs such as bortezomib with image-guided interventional oncologic procedures? Radiology 2008;248(2):323-325.
3. Livraghi T. Role of percutaneous ethanol injection in the treatment of hepatocellular carcinoma. Dig Dis 2001;19(4):292-300. (Pubitemid 34297997)
4. Goldberg EP, Hadba AR, Almond BA, Marotta JS. Intratumoral cancer chemotherapy and immunotherapy: opportunities for nonsystemic preoperative drug delivery. J Pharm Pharmacol 2002;54(2):159-180. (Pubitemid 34150053)
5. Llovet JM, Bruix J. Systematic review of randomized trials for unresectable hepatocellular carcinoma: chemoembolization improves survival. Hepatology 2003;37(2):429-442. (Pubitemid 36152543)
6. Lewandowski RJ, Geschwind JF, Liapi E, Salem R. Transcatheter intraarterial therapies: rationale and overview. Radiology 2011;259(3):641-657.
7. Ahmed M, Goldberg SN. Combination radio-frequency thermal ablation and adjuvant IV liposomal doxorubicin increases tissue coagulation and intratumoural drug accumulation. Int J Hyperthermia 2004;20(7):781-802. (Pubitemid 39496856)
8. Gasselhuber A, Dreher MR, Negussie A, Wood BJ, Rattay F, Haemmerich D. Mathematical spatio-temporal model of drug delivery from low temperature sensitive liposomes during radiofrequency tumour ablation. Int J Hyperthermia 2010;26(5):499-513.
9. Poff JA, Allen CT, Traughber B, et al. Pulsed high-intensity focused ultrasound enhances apoptosis and growth inhibition of squamous cell carcinoma xenografts with proteasome inhibitor bortezomib. Radiology 2008;248(2):485-491.
10. Torchilin VP. Targeted pharmaceutical nanocarriers for cancer therapy and imaging. AAPS J 2007;9(2):E128-E147.
11. Yang W, Ahmed M, Elian M, et al. Do liposomal apoptotic enhancers increase tumor coagulation and end-point survival in percutaneous radiofrequency ablation of tumors in a rat tumor model? Radiology 2010;257(3):685-696.
12. Yarmolenko PS, Moon EJ, Landon C, et al. Thresholds for thermal damage to normal tissues: an update. Int J Hyperthermia 2011;27(4):320-343.
13. Riaz A, Kulik LM, Mulcahy MF, Lewandowski RJ, Salem R. Yttrium-90 radioembolization in the management of liver malignancies. Semin Oncol 2010;37(2):94-101.
14. Monsky WL, Kruskal JB, Lukyanov AN, et al. Radio-frequency ablation increases intratumoral liposomal doxorubicin accumulation in a rat breast tumor model. Radiology 2002;224(3):823-829. (Pubitemid 34919820)
15. Kelkar SS, Reineke TM. Theranostics: combining imaging and therapy. Bioconjug Chem doi: 10.1021/bc200151q. Published online August 10, 2011. Accessed August 29, 2011.
16. Venkatesan AM, Kadoury S, Abi-Jaoudeh N, et al. Real-time FDG PET guidance during biopsies and radiofrequency ablation using multimodality fusion with electromagnetic navigation. Radiology 2011;260(3):848-856.
17. Martin A, Gaya A. Stereotactic body radiotherapy: a review. Clin Oncol (R Coll Radiol) 2010;22(3):157-172.
18. Ahmed M, Brace CL, Lee FT Jr, Goldberg SN. Principles of and advances in percutaneous ablation. Radiology 2011;258(2):351-369.
19. Yang W, Ahmed M, Tasawwar B, et al. Radiofrequency ablation combined with liposomal quercetin to increase tumour destruction by modulation of heat shock protein production in a small animal model. Int J Hyperthermia 2011;27(6):527-538.
20. Ganapathy-Kanniappan S, Vali M, Kunjithapatham R, et al. 3-bromopyruvate: a new targeted antiglycolytic agent and a promise for cancer therapy. Curr Pharm Biotechnol 2010;11(5):510-517.
21. Yuan X, Naguib S, Wu Z. Recent advances of siRNA delivery by nanoparticles. Expert Opin Drug Deliv 2011;8(4):521-536.